Esperion Therapeutics, Inc.
ESPRDelisted Jul 13, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434868
Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.
Q3 2025 vs. Q2 2025
How the institutions holding Esperion Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 164 | 3 | 189 | +28 |
| Shares | 98.2M | 83.8K | 108.0M | +9.84M (+10.0%) |
| Value | $96.6M | $82.5K | $286.1M | +$189.5M (+196.3%) |
3 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (48)
Institutions that held Esperion Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (20)
Institutions that held Esperion Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Indaba Capital Management, L.P. | 3,000,000 | $2.95M |
| Qube Research & Technologies Ltd | 485,603 | $478.0K |
| UBS Asset Management Americas Inc | 249,500 | $245.5K |
| State of Wyoming | 122,532 | $120.6K |
| Virtu Financial LLC | 76,622 | $75.0K |
| Quadrature Capital Ltd | 46,274 | $45.6K |
| Alpine Global Management, LLC | 17,731 | $17.5K |
| Neuberger Berman Group LLC | 14,250 | $14.0K |
| HSBC Holdings PLC | 13,703 | $13.8K |
| Wolverine Trading, LLC | 10,805 | $10.7K |
| Herbst Group, LLC | 10,300 | $10.1K |
| Baxter Bros Inc | 10,000 | $9.84K |
| Wealthcare Advisory Partners LLC | 10,000 | $9.84K |
| Apollon Wealth Management, LLC | 10,000 | $9.84K |
| Raiffeisen Bank International AG | 4,400 | $4.33K |
| National Bank of Canada | 2,300 | $2.27K |
| Barrett & Company, Inc. | 300 | $295 |
| Trust Co of Vermont | 300 | $295 |
| Sunbelt Securities, Inc. | 100 | $220 |
| Bessemer Group Inc | 127 | $0 |
Not filed for Q3 2025 yet (3)
Institutions that held Esperion Therapeutics, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Congress Wealth Management LLC | 46,300 | $45.6K |
| CIBC World Markets Corp | 24,604 | $24.2K |
| Avantax Advisory Services, Inc. | 12,877 | $12.7K |